Bevacizumab plus etoposide among recurrent malignant glioma patients: Phase II study final results
Year: 2009
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: Duke Medical Center
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3080428147
